Cargando…
Clinical Features, Treatment, and Outcome of HIV-Associated Immune Thrombocytopenia in the HAART Era
The characteristics of HIV-associated ITP were documented prior to the HAART era, and the optimal treatment beyond HAART is unknown. We performed a review of patients with HIV-associated ITP and at least one platelet count <20 × 10(9)/L since January 1996. Of 5290 patients in the BC Centre for Ex...
Autores principales: | Ambler, Kimberley L. S., Vickars, Linda M., Leger, Chantal S., Foltz, Lynda M., Montaner, Julio S. G., Harris, Marianne, Dias Lima, Viviane, Leitch, Heather A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3368161/ https://www.ncbi.nlm.nih.gov/pubmed/22693513 http://dx.doi.org/10.1155/2012/910954 |
Ejemplares similares
-
HIV-Associated Burkitt Lymphoma: Good Efficacy and Tolerance of Intensive Chemotherapy Including CODOX-M/IVAC with or without Rituximab in the HAART Era
por: Rodrigo, J. A., et al.
Publicado: (2012) -
Expanding HAART Treatment to All Currently Eligible Individuals under the 2008 IAS-USA Guidelines in British Columbia, Canada
por: Lima, Viviane D., et al.
Publicado: (2010) -
Autoimmune Syndromes Presenting as a Paraneoplastic Manifestation of Myelodysplastic Syndromes: Clinical Features, Course, Treatment and Outcome
por: Williamson, Bradley T., et al.
Publicado: (2016) -
Neurodegeneration in the HAART era
por: Brew, Bruce J
Publicado: (2010) -
Red Blood Cell Transfusion Independence Following the Initiation of Iron Chelation Therapy in Myelodysplastic Syndrome
por: Badawi, Maha A., et al.
Publicado: (2010)